Filing Flows › Crispr Therapeutics AG (CRSP) › How it makes money
How Crispr Therapeutics AG (CRSP) makes money
Crispr Therapeutics AG (CRSP) made $12.7M of revenue in the third quarter 2026 (Q3 2026), up 14-fold from a year earlier. Collaboration Revenue brought in $12.3M (97%); Grant brought in $346K (3%).
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Collaboration Revenue | $12.3M | 97.3% | +23% | — |
| Grant | $346K | 2.7% | +91% | -61% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $12.7M | 100.0% |
| Income tax | $74K | 0.6% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $12.7M | 14× |
| Q2 2026 | $10.2M | 11× |
| Q1 2026 | $1.5M | +69% |
| Q4 2025 | $864K | -98% |
| Q3 2025 | $889K | +48% |
| Q2 2025 | $892K | +72% |
| Q1 2025 | $865K | +72% |
From Crispr Therapeutics AG's 10-Q filed Nov 2, 2026 (on EDGAR).
Questions
How does Crispr Therapeutics AG make money?
Crispr Therapeutics AG (CRSP) made $12.7M of revenue in the third quarter 2026 (Q3 2026), up 14-fold from a year earlier. Collaboration Revenue brought in $12.3M (97%); Grant brought in $346K (3%).
What is Crispr Therapeutics AG's biggest business?
Collaboration Revenue: $12.3M in the third quarter 2026, 97% of revenue.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.